Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.18 | 9e-05 |
mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.12 | 0.003 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.077 | 0.07 |
mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.076 | 0.1 |
mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.066 | 0.2 |
mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.052 | 0.3 |